Precigen (PGEN) Accounts Payables (2012 - 2026)
Precigen's (PGEN) quarterly Accounts Payables came in at $2.6 million in Q1 2026, down 16.67% year-on-year from $3.1 million in Q1 2025, and down 78.4% on a QoQ basis from $12.0 million in Q4 2025.
Precigen (PGEN) Accounts Payables (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Accounts Payables data on file, last reported at $2.6 million in Q1 2026.
- On a quarterly basis, Accounts Payables fell 16.67% year-over-year to $2.6 million in Q1 2026; TTM through Mar 2026 was $2.6 million, a 16.67% decrease from a year earlier, with the FY2025 full-year figure at $12.0 million, up 239.42% from the prior year.
- Accounts Payables for Q1 2026 stood at $2.6 million, down from $12.0 million in the prior quarter.
- Over the last five years, Accounts Payables for PGEN reached as high as $12.0 million in Q4 2025 and fell as low as $1.7 million in Q4 2023.
- Historically, Accounts Payables has averaged $4.2 million across 5 years, with a median of $3.9 million in 2025.
- Across the five-year window, Accounts Payables tumbled 57.57% in 2023 and surged 239.42% in 2025, its largest moves.
- Year by year, Accounts Payables stood at $4.1 million in 2022, then tumbled by 57.57% to $1.7 million in 2023, then jumped by 104.58% to $3.5 million in 2024, then jumped by 239.42% to $12.0 million in 2025, then slumped by 78.4% to $2.6 million in 2026.
- Per Business Quant data, the three most recent Accounts Payables figures were $2.6 million in Q1 2026, $12.0 million in Q4 2025, and $6.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn | 2.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.59 Mn |
| Dec 31, 2025 | 11.99 Mn |
| Sep 30, 2025 | 6.26 Mn |
| Jun 30, 2025 | 3.92 Mn |
| Mar 31, 2025 | 3.11 Mn |
| Dec 31, 2024 | 3.53 Mn |
| Sep 30, 2024 | 4.32 Mn |
| Jun 30, 2024 | 4.85 Mn |
| Mar 31, 2024 | 4.72 Mn |
| Dec 31, 2023 | 1.73 Mn |
| Sep 30, 2023 | 2.35 Mn |
| Jun 30, 2023 | 2.51 Mn |
| Mar 31, 2023 | 3.81 Mn |
| Dec 31, 2022 | 4.07 Mn |
| Sep 30, 2022 | 4.20 Mn |
| Jun 30, 2022 | 2.67 Mn |
| Mar 31, 2022 | 4.42 Mn |
| Dec 31, 2021 | 3.11 Mn |
| Sep 30, 2021 | 3.62 Mn |
| Jun 30, 2021 | 4.94 Mn |